Meta-Analysis of the Efficacy and Safety of Imidafenacin for Overactive Bladder Induced by Benign Prostatic Hyperplasia in Men Receiving Alpha-Blocker Therapy
Tong Cai, Ning Wang, Liye Liang, Zhongbao Zhou, Yong Zhang, Yuanshan Cui
Int Neurourol J. 2020;24(4):365-374.   Published online 2020 Dec 31
Citations to this article as recorded by
  Crossref logo
Comparison of add-on medications for persistent storage symptoms after α-blocker treatment in BPH patients – a network meta-analysis
Yi-Ting Su, Hsiao-Ling Chen, Jeremy Yuen-Chun Teoh, Vinson Wai-Shun Chan, Wen-Jeng Wu, Hsiang-Ying Lee
BMC Urology.2023;[Epub]     CrossRef
A comprehensive review of medical therapy on benign prostatic hyperplasia
R. Sugianto, P.M.W. Tirtayasa, G.W.K. Duarsa
Sexologies.2022; 31(1): 52.     CrossRef
Improvement in Near Vision Following Silodosin Treatment in Patients With Lower Urinary Tract Symptoms
Hyun Jin Shin, Woo Suk Choi, Shin-Hyo Lee, Andrew G. Lee, Aram Kim, Hyoung Keun Park, Sung Hyun Paick, Hyeong Gon Kim
International Neurourology Journal.2021; 25(2): 164.     CrossRef
Postoperative medical treatment of lower urinary tract symptoms after benign prostatic hyperplasia surgery. Are we underestimating the problem?
Leonid Spivak, Andrey Morozov, Anastasia Shpikina, Dmitry Enikeev, Leonid Rapoport
Current Opinion in Urology.2021; 31(5): 451.     CrossRef
Reply to Commentary on “Changes in Prevalence and Treatment Pattern of Benign Prostatic Hyperplasia in Korea”
Jung Ki Jo, Sung Ho Shinn, Kyu Shik Kim, Hong Sang Moon
International Neurourology Journal.2021; 25(4): 365.     CrossRef